vs
阿普塔集团（ATR）与Cloudflare, Inc.（NET）财务数据对比。点击上方公司名可切换其他公司
阿普塔集团的季度营收约是Cloudflare, Inc.的1.6倍（$962.7M vs $614.5M），阿普塔集团净利率更高（7.7% vs -2.0%，领先9.7%），Cloudflare, Inc.同比增速更快（33.6% vs 13.5%），Cloudflare, Inc.自由现金流更多（$105.2M vs $96.9M），过去两年Cloudflare, Inc.的营收复合增速更高（27.4% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Cloudflare是总部位于美国加利福尼亚州旧金山的科技企业，提供内容分发网络（CDN）、云网络安全、DDoS防护等多元互联网服务，同时是ICANN认证的域名注册商。其服务作为网站访客与客户托管服务商之间的反向代理，可有效提升访问性能，抵御恶意流量。
ATR vs NET — 直观对比
营收规模更大
ATR
是对方的1.6倍
$614.5M
营收增速更快
NET
高出20.1%
13.5%
净利率更高
ATR
高出9.7%
-2.0%
自由现金流更多
NET
多$8.3M
$96.9M
两年增速更快
NET
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $614.5M |
| 净利润 | $74.3M | $-12.1M |
| 毛利率 | — | 73.6% |
| 营业利润率 | 11.0% | -8.0% |
| 净利率 | 7.7% | -2.0% |
| 营收同比 | 13.5% | 33.6% |
| 净利润同比 | -26.4% | 6.0% |
| 每股收益（稀释后） | $1.13 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRNET
| Q4 25 | $962.7M | $614.5M | ||
| Q3 25 | $961.1M | $562.0M | ||
| Q2 25 | $966.0M | $512.3M | ||
| Q1 25 | $887.3M | $479.1M | ||
| Q4 24 | $848.1M | $459.9M | ||
| Q3 24 | $909.3M | $430.1M | ||
| Q2 24 | $910.1M | $401.0M | ||
| Q1 24 | $915.4M | $378.6M |
净利润ATRNET
| Q4 25 | $74.3M | $-12.1M | ||
| Q3 25 | $127.9M | $-1.3M | ||
| Q2 25 | $111.7M | $-50.4M | ||
| Q1 25 | $78.8M | $-38.5M | ||
| Q4 24 | $100.9M | $-12.8M | ||
| Q3 24 | $100.0M | $-15.3M | ||
| Q2 24 | $90.5M | $-15.1M | ||
| Q1 24 | $83.1M | $-35.5M |
毛利率ATRNET
| Q4 25 | — | 73.6% | ||
| Q3 25 | — | 74.0% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 77.7% | ||
| Q2 24 | — | 77.8% | ||
| Q1 24 | — | 77.5% |
营业利润率ATRNET
| Q4 25 | 11.0% | -8.0% | ||
| Q3 25 | 14.2% | -6.7% | ||
| Q2 25 | 14.9% | -13.1% | ||
| Q1 25 | 12.8% | -11.1% | ||
| Q4 24 | 14.2% | -7.5% | ||
| Q3 24 | 15.2% | -7.2% | ||
| Q2 24 | 13.8% | -8.7% | ||
| Q1 24 | 12.2% | -14.4% |
净利率ATRNET
| Q4 25 | 7.7% | -2.0% | ||
| Q3 25 | 13.3% | -0.2% | ||
| Q2 25 | 11.6% | -9.8% | ||
| Q1 25 | 8.9% | -8.0% | ||
| Q4 24 | 11.9% | -2.8% | ||
| Q3 24 | 11.0% | -3.6% | ||
| Q2 24 | 9.9% | -3.8% | ||
| Q1 24 | 9.1% | -9.4% |
每股收益（稀释后）ATRNET
| Q4 25 | $1.13 | $-0.03 | ||
| Q3 25 | $1.92 | $0.00 | ||
| Q2 25 | $1.67 | $-0.15 | ||
| Q1 25 | $1.17 | $-0.11 | ||
| Q4 24 | $1.48 | $-0.05 | ||
| Q3 24 | $1.48 | $-0.04 | ||
| Q2 24 | $1.34 | $-0.04 | ||
| Q1 24 | $1.23 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $943.5M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $1.5B |
| 总资产 | $5.3B | $6.0B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRNET
| Q4 25 | $409.5M | $943.5M | ||
| Q3 25 | $264.8M | $1.1B | ||
| Q2 25 | $169.8M | $1.5B | ||
| Q1 25 | $136.8M | $204.5M | ||
| Q4 24 | $226.2M | $147.7M | ||
| Q3 24 | $327.9M | $182.9M | ||
| Q2 24 | $223.9M | $157.0M | ||
| Q1 24 | $201.1M | $254.4M |
总债务ATRNET
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
股东权益ATRNET
| Q4 25 | $2.7B | $1.5B | ||
| Q3 25 | $2.8B | $1.3B | ||
| Q2 25 | $2.7B | $1.2B | ||
| Q1 25 | $2.5B | $1.4B | ||
| Q4 24 | $2.5B | $1.0B | ||
| Q3 24 | $2.5B | $973.1M | ||
| Q2 24 | $2.4B | $881.5M | ||
| Q1 24 | $2.3B | $797.2M |
总资产ATRNET
| Q4 25 | $5.3B | $6.0B | ||
| Q3 25 | $5.1B | $5.8B | ||
| Q2 25 | $4.9B | $5.6B | ||
| Q1 25 | $4.5B | $3.7B | ||
| Q4 24 | $4.4B | $3.3B | ||
| Q3 24 | $4.6B | $3.1B | ||
| Q2 24 | $4.5B | $2.9B | ||
| Q1 24 | $4.4B | $2.8B |
负债/权益比ATRNET
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $190.4M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $105.2M |
| 自由现金流率自由现金流/营收 | 10.1% | 17.1% |
| 资本支出强度资本支出/营收 | 9.0% | 13.9% |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | $287.5M |
8季度趋势，按日历期对齐
经营现金流ATRNET
| Q4 25 | $183.7M | $190.4M | ||
| Q3 25 | $177.6M | $167.1M | ||
| Q2 25 | $126.0M | $99.8M | ||
| Q1 25 | $82.7M | $145.8M | ||
| Q4 24 | $178.2M | $127.3M | ||
| Q3 24 | $229.3M | $104.7M | ||
| Q2 24 | $143.6M | $74.8M | ||
| Q1 24 | $92.3M | $73.6M |
自由现金流ATRNET
| Q4 25 | $96.9M | $105.2M | ||
| Q3 25 | $114.3M | $82.5M | ||
| Q2 25 | $62.5M | $39.9M | ||
| Q1 25 | $25.9M | $59.9M | ||
| Q4 24 | $112.2M | $54.2M | ||
| Q3 24 | $162.7M | $54.5M | ||
| Q2 24 | $75.4M | $45.2M | ||
| Q1 24 | $16.7M | $41.5M |
自由现金流率ATRNET
| Q4 25 | 10.1% | 17.1% | ||
| Q3 25 | 11.9% | 14.7% | ||
| Q2 25 | 6.5% | 7.8% | ||
| Q1 25 | 2.9% | 12.5% | ||
| Q4 24 | 13.2% | 11.8% | ||
| Q3 24 | 17.9% | 12.7% | ||
| Q2 24 | 8.3% | 11.3% | ||
| Q1 24 | 1.8% | 11.0% |
资本支出强度ATRNET
| Q4 25 | 9.0% | 13.9% | ||
| Q3 25 | 6.6% | 15.1% | ||
| Q2 25 | 6.6% | 11.7% | ||
| Q1 25 | 6.4% | 17.9% | ||
| Q4 24 | 7.8% | 15.9% | ||
| Q3 24 | 7.3% | 11.7% | ||
| Q2 24 | 7.5% | 7.4% | ||
| Q1 24 | 8.3% | 8.5% |
现金转化率ATRNET
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
NET
| Sales Channel Directly To Consumer | $438.5M | 71% |
| Sales Channel Through Intermediary | $176.0M | 29% |
